Combination of doses, better than monotherapy for pulmonary hypertension

Published Date: 08 Mar 2023

People with hypertension (high blood pressure in the arteries that supply the lungs, also known as PAH) have up to a two-fold reduction in pulmonary vascular resistance (PVR) when taking PAH.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC

2.

Virtual Reality Travel Reduces Cancer Pain.

3.

NEJM: Pirtobrutinib is effective in CLL patients who have received prior BTK inhibitor therapy.

4.

Even a few mutated cells can significantly impact how blood cancers develop, study finds

5.

Omitting Biopsy After Negative MRI Halves Diagnoses of Insignificant Prostate Cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot